Does "late catch-up" exist in drug-eluting stents: Insights from a serial quantitative coronary angiography analysis of sirolimus versus paclitaxel-eluting stents

American Heart Journal

Volumn 159, Issue 3, 2010, Pages

  Park, Kyung Woo ^a   Kim, Chi Hoon ^a   Lee, Hae Young ^a   Kang, Hyun Jae ^a   Koo, Bon Kwon ^a   Oh, Byung Hee ^a   Park, Young Bae ^a   Kim, Hyo Soo ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTERY INTIMA PROLIFERATION; ARTICLE; CARDIAC PATIENT; CONTROLLED STUDY; CORONARY STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IMAGE ANALYSIS; IN-STENT RESTENOSIS; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STABLE ANGINA PECTORIS; THERAPY DELAY; THERAPY EFFECT; UNSTABLE ANGINA PECTORIS;

EID: 77649109030     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.01.001     Document Type: Article

References (20)

1. Sheiban I., Chiribiri A., Galli S., et al. Sirolimus-eluting stent implantation for bare-metal in-stent restenosis: is there any evidence for a late catch-up phenomenon?. J Cardiovasc Med 9 (2008) 783-788
2. Awata M., Kotani J., Uematsu M., et al. Serial angiographic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents. Circulation 116 (2007) 910-916
3. Sousa J.E., Costa M.A., Abizaid A., et al. Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents. Circulation 111 (2005) 2326-2329
4. Serruys PW, On behalf of the SPIRIT II investigators. SPIRIT II study: a clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions. ACC i2 summit, March 30 to April 1, 2008 Chicago.
5. Kimura T., Yokoi H., Nakagawa Y., et al. Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med 335 (1996) 561-566
6. Serruys P.W., Luijten H.E., Beatt K.J., et al. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. Circulation 77 (1988) 361-371
7. Daemen J., Tanimoto S., García-García H.M., et al. Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH registries). Am J Cardiol 99 (2007) 1027-1032
8. Windecker S., Remondino A., Eberli F.R., et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 353 (2005) 653-662
9. Morice M.C., Colombo A., Meier B., et al. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY Trial : a randomized controlled trial. JAMA 295 (2006) 895-904
10. Dibra A., Kastrati A., Mehilli J., et al. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 353 (2005) 663-670
11. Vaz V.D., Abizaid A., Chaves A., et al. Long-term follow up of diabetic patients treated with sirolimus-eluting stents. an angiographic and three-dimensional intravascular ultrasound study. J Invasive Cardiol 18 (2006) 142-146
12. Shiode N., Shirota K., Goto K., et al. Comparison of long-term angiographic follow-up after sirolimus-eluting stent and bare-metal stent implantation. Intern Med 47 (2008) 201-204
13. Planer D., Beyar R., Almagor Y., et al. Long-term (>3 years) outcome and predictors of clinical events after insertion of sirolimus-eluting stent in one or more native coronary arteries (from the Israeli arm of the e-Cypher registry). Am J Cardiol 101 (2008) 953-959
14. Tsuchida K., Serruys P.W., Bruining N., et al. Two-year serial coronary angiographic and intravascular ultrasound analysis of in-stent angiographic late lumen loss and ultrasonic neointimal volume from the TAXUS II trial. Am J Cardiol 99 (2007) 607-615
15. Dawkins K.D., Grube E., Guagliumi G., et al. TAXUS VI Investigators. Clinical efficacy of polymer based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial. Support for the use of drug-eluting stents in contemporary clinical practice. Circulation 112 (2005) 3306-3313
16. Kastrati A., Schömig A., Elezi S., et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 30 (1997) 1428-1436
17. Yoneyama K., Tsuboya A., Kogo M., et al. Predictors of restenosis after coronary artery stenting. Minerva Cardioangiol 56 (2008) 295-305
18. Agostoni P., Valgimigli M., Abbate A., et al. Is late luminal loss and accurate predictor of the clinical effectiveness of drug-eluting stents in the coronary arteries?. Am J Cardiol 97 (2006) 603-605
19. Pocock S.J., Lansky A.J., Mehran R., et al. Angiographic surrogate end points in drug-eluting stent trials. J Am Coll Cardiol 51 (2008) 23-32
20. Mauri L., Orav E.J., and Kuntz R.E. Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation 111 (2005) 3435-3442